Peter Gerhardsson

Peter Gerhardsson has extensive experience with diabetes therapies. From 1980 to 2000, he held various roles at Novo Nordisk. In 2000, he joined MiniMed, which Medtronic acquired in 2001 and where he continued to lead its European diabetes business. Subsequently, he joined Dexcom as Vice President International Business Development, from 2008 till his retirement in 2018. Thereafter, he joined Institute for Applied Economics and Health Research in Copenhagen as Partner.